Abstract
Many synaptic adhesion molecules positively regulate synapse development and function, but relatively little is known about negative regulation. SALM4/Lrfn3 (synaptic adhesion-like molecule 4/leucine rich repeat and fibronectin type III domain containing 3) inhibits synapse development by suppressing other SALM family proteins, but whether SALM4 also inhibits synaptic function and specific behaviors remains unclear. Here we show that SALM4-knockout (Lrfn3−/−) male mice display enhanced contextual fear memory consolidation (7-day post-training) but not acquisition or 1-day retention, and exhibit normal cued fear, spatial, and object-recognition memory. The Lrfn3−/− hippocampus show increased currents of GluN2B-containing N-methyl-d-aspartate (NMDA) receptors (GluN2B-NMDARs), but not α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors (AMPARs), which requires the presynaptic receptor tyrosine phosphatase PTPσ. Chronic treatment of Lrfn3−/− mice with fluoxetine, a selective serotonin reuptake inhibitor used to treat excessive fear memory that directly inhibits GluN2B-NMDARs, normalizes NMDAR function and contextual fear memory consolidation in Lrfn3−/− mice, although the GluN2B-specific NMDAR antagonist ifenprodil was not sufficient to reverse the enhanced fear memory consolidation. These results suggest that SALM4 suppresses excessive GluN2B-NMDAR (not AMPAR) function and fear memory consolidation (not acquisition).
Highlights
Many synaptic adhesion molecules positively regulate synapse development and function, but relatively little is known about negative regulation
We found that SALM4-knockout (KO) (Lrfn3−/−) mice displayed abnormally increased NMDARmediated, but not AMPAR-mediated, synaptic transmission involving the NMDAR GluN2B subunit and the presynaptic receptor tyrosine phosphatase PTPσ
Lrfn3−/− mice showed normal extinction of acquired contextual fear memory, there is a decreasing tendency (Fig. 1g, h). These results suggest that SALM4 deletion enhances contextual fear memory consolidation without affecting acquisition or 1-day retention or cued fear memory
Summary
Many synaptic adhesion molecules positively regulate synapse development and function, but relatively little is known about negative regulation. SALM4/Lrfn[3] (synaptic adhesion-like molecule 4/leucine rich repeat and fibronectin type III domain containing 3) inhibits synapse development by suppressing other SALM family proteins, but whether SALM4 inhibits synaptic function and specific behaviors remains unclear. A large number of synaptic adhesion molecules have been identified, with neuroligins and neurexins being prototypical molecules[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15] Many of these molecules positively regulate synapse development and function, but relatively little is known about negative regulation by these proteins, of synapse functions such as postsynaptic receptor responses. Whether SALM4 negatively regulates synaptic functions such as postsynaptic NMDAR responses and any related behaviors remains unclear
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.